Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Inflammation 2001--fifth world congress. Chronic obstructive pulmonary disease.

Burgaud JL.

IDrugs. 2001 Nov;4(11):1208-9. No abstract available.

PMID:
15942815
2.

A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.

Lagente V, Naline E, Guenon I, Corbel M, Boichot E, Burgaud JL, Del Soldato P, Advenier C.

J Pharmacol Exp Ther. 2004 Jul;310(1):367-75. Epub 2004 Apr 14.

PMID:
15084649
3.

Nitric oxide-releasing non steroidal anti-inflammatory drugs: a new generation of anti-tumoral molecules.

Lavagna C, Del Soldato P, Burgaud JL, Rampal P.

Curr Cancer Drug Targets. 2003 Dec;3(6):407-26. Review.

PMID:
14683499
4.

Therapeutic strategy for asthma: NO body is perfect.

Burgaud JL.

Respiration. 2002;69(6):480-1. No abstract available.

PMID:
12456998
5.

Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents.

Burgaud JL, Ongini E, Del Soldato P.

Ann N Y Acad Sci. 2002 May;962:360-71. Review.

PMID:
12076987
6.

Nitric-oxide releasing molecules: a new class of drugs with several major indications.

Burgaud JL, Riffaud JP, Del Soldato P.

Curr Pharm Des. 2002;8(3):201-13. Review.

PMID:
11864065
7.

NO-steroids: potent anti-inflammatory drugs with bronchodilating activity in vitro.

Tallet D, Del Soldato P, Oudart N, Burgaud JL.

Biochem Biophys Res Commun. 2002 Jan 11;290(1):125-30.

PMID:
11779143
8.

Nitric oxide-releasing NSAIDs: a review of their current status.

Fiorucci S, Antonelli E, Burgaud JL, Morelli A.

Drug Saf. 2001;24(11):801-11. Review.

PMID:
11665868
9.

Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.

Lavagna C, Burgaud JL, Del Soldato P, Rampal P.

Biochem Biophys Res Commun. 2001 Jun 15;284(3):808-16.

PMID:
11396974
10.

Involvement of cyclooxygenase 2 in the protective effect of 17beta-estradiol on hypercholesterolemic rabbit aorta.

Ghanam K, Lavagna C, Burgaud JL, Javellaud J, Ea-Kim L, Oudart N.

Biochem Biophys Res Commun. 2000 Aug 28;275(2):696-703.

PMID:
10964725
11.

Melanin-concentrating hormone binding sites in human SVK14 keratinocytes.

Burgaud JL, Poosti R, Fehrentz JA, Martinez J, Nahon JL.

Biochem Biophys Res Commun. 1997 Dec 29;241(3):622-9.

PMID:
9434758
12.

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM.

Cancer Res. 1997 Aug 1;57(15):3079-83.

13.
14.

[Pharmacological approach of histamine H3 receptors: use of arterial and bronchiolar perfusion technique].

Oudart N, Kim LE, Burgaud JL.

Ann Pharm Fr. 1996;54(5):217-22. French.

PMID:
8953796
16.
17.

Mutant IGF-I receptors as dominant negatives for growth and transformation.

Burgaud JL, Resnicoff M, Baserga R.

Biochem Biophys Res Commun. 1995 Sep 14;214(2):475-81.

PMID:
7677754
18.

Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.

Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R.

Cancer Res. 1995 Sep 1;55(17):3739-41.

20.
21.

Do perfused small caliber airways of guinea-pig release an epithelium-dependent relaxing factor?

Burgaud JL, Javellaud J, Oudart N.

Pulm Pharmacol. 1993 Sep;6(3):217-24.

PMID:
8219576
23.

Supplemental Content

Loading ...
Support Center